Overview

Breast Imaging Market is estimated to value over USD 5.8 billion by 2027 end with a CAGR of over 7.9% during the forecast period 2020 to 2027.

Technological advancements, increased occurrence of breast cancer, rise in the screening programs along with symposiums and conferences emphasizing on creating awareness regarding the advantages of early diagnosis and screening are the primary contributors to the breast imaging market growth. Furthermore, increasing private and public investments for meeting the rising insistence for breast cancer screenings and improvements in reimbursement policies are some other factors responsible for the proliferation of the market.

Breast Imaging Market

Market Segmentation:

By Technology
• Ionizing Breast Imaging
o Mammography
• Full-field Digital Mammography (FFDM)
• 3D Breast Tomosynthesis
• Analog Mammography
o Positron Emission Tomography-Computed Tomography (PET-CT)
o Molecular Breast Imaging (MBI)
o Positron Emission Mammography (PEM)
o Cone-beam Computed Tomography (CBCT)
• Non-ionizing Breast Imaging
o Breast Ultrasound
o Breast MRI
o Automated Whole-breast Ultrasound (AWBU)
o Breast thermography
o Electric Impedance Tomography
o Optical Imaging

By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into technology, and region. The technology segment is classified into non-ionizing breast imaging and ionizing breast imaging technologies. The non-ionizing breast imaging is predicted to proliferate during the forecasted period, and this can be credited to the benefits provided by non-ionizing technology like high sensitivity to small breast lesions and better creation of anatomical details. The ionizing breast imaging segment is divided into mammography, PET-CT, molecular breast imaging, positron emission mammography, cone beam computed tomography (CBCT).

Regional Analysis:

The North America region is expected to lead the market due to advancements in technologies that can help in early diagnosis of cancer tumor, increasing prevalence of breast cancer in the region owing to unhealthy lifestyle and a lack of awareness regarding the development of breast cancer.

Competitive Landscape:

Some of the prominent players are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, Carestream Health.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global breast imaging market by technology and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com